Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

ffects of Formyl Peptide Receptor Agonists Ac9-12 and WKYMV in In Vivo and In Vitro Acute Inflammatory Experimental Model

Texto completo
Autor(es):
Lice, Izabella [1] ; Sanches, Jose Marcos [2] ; Correia-Silva, Rebeca D. [1] ; Correa, Mab P. [3] ; Icimoto, Marcelo Y. [4] ; Silva, Alex A. R. [5] ; Sanchez-Vinces, Salvador [5] ; Porcari, Andreia M. [5] ; Moreira, Vanessa [6] ; Gil, Cristiane D. [1, 3, 7]
Número total de Autores: 10
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo UNIFESP, Dept Morphol & Genet, BR-04023900 Sao Paulo, SP - Brazil
[2] UT Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 - USA
[3] Univ Estadual Paulista UNESP, Inst Biosci Humanities & Exact Sci, BR-15054000 Sao Jose Do Rio Preto, SP - Brazil
[4] Univ Estadual Paulista UNESP, Dept Biophys, BR-04039032 Sao Paulo, SP - Brazil
[5] Sao Francisco Univ, Hlth Sci Postgrad Program, MS4Life Lab Mass Spectrometry, BR-12916900 Braganca Paulista, SP - Brazil
[6] Univ Fed Sao Paulo UNIFESP, Dept Pharmacol, BR-04044020 Sao Paulo, SP - Brazil
[7] Univ Fed Sao Paulo UNIFESP, Dept Morfol & Genet, Rua Botucatu 740, Ed Lemos Torres 3 Andar, BR-04023900 Sao Paulo, SP - Brazil
Número total de Afiliações: 7
Tipo de documento: Artigo Científico
Fonte: CELLS; v. 11, n. 2 JAN 2022.
Citações Web of Science: 0
Resumo

Formyl peptide receptors (Fprs) are a G-protein-coupled receptor family mainly expressed on leukocytes. The activation of Fpr1 and Fpr2 triggers a cascade of signaling events, leading to leukocyte migration, cytokine release, and increased phagocytosis. In this study, we evaluate the effects of the Fpr1 and Fpr2 agonists Ac9-12 and WKYMV, respectively, in carrageenan-induced acute peritonitis and LPS-stimulated macrophages. Peritonitis was induced in male C57BL/6 mice through the intraperitoneal injection of 1 mL of 3% carrageenan solution or saline (control). Pre-treatments with Ac9-12 and WKYMV reduced leukocyte influx to the peritoneal cavity, particularly neutrophils and monocytes, and the release of IL-1 beta. The addition of the Fpr2 antagonist WRW4 reversed only the anti-inflammatory actions of WKYMV. In vitro, the administration of Boc2 and WRW4 reversed the effects of Ac9-12 and WKYMV, respectively, in the production of IL-6 by LPS-stimulated macrophages. These biological effects of peptides were differently regulated by ERK and p38 signaling pathways. Lipidomic analysis evidenced that Ac9-12 and WKYMV altered the intracellular lipid profile of LPS-stimulated macrophages, revealing an increased concentration of several glycerophospholipids, suggesting regulation of inflammatory pathways triggered by LPS. Overall, our data indicate the therapeutic potential of Ac9-12 and WKYMV via Fpr1 or Fpr2-activation in the inflammatory response and macrophage activation. (AU)

Processo FAPESP: 19/15017-2 - Efeito biológico de peptídeos derivados da proteína anexina A1 em modelos de inflamação in vitro
Beneficiário:Izabella Lice Moura
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 20/03565-2 - Efeito da anexina A1 e de seus peptídeos miméticos em modelos de resposta inflamatória in vitro (2D e 3D) e de toxicidade aguda in vivo
Beneficiário:Cristiane Damas Gil
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 19/04314-6 - Imageamento e metabolômica por espectrometria de massas aplicada ao estudo de resistência à terapia neoadjuvante para tratamento de câncer de mama: busca por um teste preditivo
Beneficiário:Andréia de Melo Porcari
Modalidade de apoio: Auxílio à Pesquisa - Regular